Skip to main navigation Skip to search Skip to main content

CT-Screening for lung cancer does not increase the use of anxiolytic or antidepressant medication

Linda Kaerlev, Maria Iachina, Jesper Holst Pedersen, Anders Christian Green, Bente Mertz Nørgård

    22 Citations (Scopus)

    Abstract

    CT screening for lung cancer has recently been shown to reduce lung cancer mortality, but screening may have adverse mental health effects. We calculated risk ratios for prescription of anti-depressive (AD) or anxiolytic (AX) medication redeemed at Danish pharmacies for participants in The Danish Lung Cancer Screening Trial (DLCST).
    Original languageEnglish
    JournalB M C Cancer
    Volume12
    Pages (from-to)188
    ISSN1471-2407
    DOIs
    Publication statusPublished - 2012

    Keywords

    • Adult
    • Aged
    • Anti-Anxiety Agents
    • Antidepressive Agents
    • Anxiety
    • Comorbidity
    • Depression
    • Drug Utilization
    • Early Detection of Cancer
    • Female
    • Follow-Up Studies
    • Humans
    • Lung Neoplasms
    • Male
    • Mass Screening
    • Middle Aged
    • Risk
    • Tomography, X-Ray Computed

    Fingerprint

    Dive into the research topics of 'CT-Screening for lung cancer does not increase the use of anxiolytic or antidepressant medication'. Together they form a unique fingerprint.

    Cite this